BinaxNOW COVID-19 Antigen Self Test
FDA 510(k) K243518 · Abbott Diagnostics Scarborough, Inc.
510(k) numberK243518
Submission
- Device name
- BinaxNOW COVID-19 Antigen Self Test
- Applicant
- Abbott Diagnostics Scarborough, Inc.
Scarborough, ME, US - Received
- November 13, 2024
- Decision date
- February 11, 2025
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- QYT – Over-The-Counter Covid-19 Antigen Test
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.3984
- Specialty
- Microbiology
For the rapid, qualitative detection of SARS-CoV-2 virus nucleocapsid protein antigen in individuals 2 years and older.
Other 510(k)s with product code QYT
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K260754 | Fastep COVID-19 Antigen Pen Home Test; Fastep COVID-19 Antigen Pen TestQYT · Traditional | Assure Tech., LLC | 06/05/2026SE |
| K260095 | Heal-Check Rapid COVID-19 Antigen Self-TestQYT · Traditional | Healgen Scientific,, LLC | 04/13/2026SE |
| K251916 | GenBody COVID-19 Ag Home TestQYT · Traditional | Genbody.Inc. | 03/13/2026SE |
| K251595 | COVID-19 Detect Rapid Self -TestQYT · Traditional | InBios International, Inc. | 10/12/2025SE |
| K251753 | GenaCheck COVID-19 Rapid Self-TestQYT · Traditional | Genabio Diagnostics, Inc. | 09/05/2025SE |
| K241313 | OHC COVID-19 Antigen Self TestQYT · Traditional | Osang, LLC | 05/30/2025SE |
| K241915 | CareSuperb COVID-19 Antigen Home TestQYT · Traditional | Access Bio, Inc. | 01/29/2025SE |
| K241317 | Wondfo 2019-nCoV Antigen Test (Lateral Flow Method)QYT · Traditional | Guangzhou Wondfo Biotech Co., Ltd. | 09/30/2024SE |
| K240728 | CorDx Tyfast COVID-19 Ag Rapid Test; CorDx COVID-19 Ag TestQYT · Traditional | CorDx, Inc. | 06/21/2024SE |
| K233842 | iHealth COVID-19 Antigen Rapid TestQYT · Traditional | Ihealth Labs, Inc. | 05/31/2024SE |
More from Ihealth Labs, Inc.
| 510(k) | Device | Decision |
|---|---|---|
| K262747 | ID NOW Influenza A & B 2; ID NOW RSV; ID NOW Strep A 2; ID NOW COVID-19 2.0OCC · Special | 08/31/2026SE |
| K250273 | BinaxNOW COVID-19 Ag CardQVF · Dual Track | 06/13/2025SE |
| K232775 | ID NOW Influenza A & B 2OCC · Special | 10/10/2023SE |
| K221925 | Id Now COVID-19 2.0QWR · Dual Track | 08/10/2023SE |
| K220801 | ID Now Instrument, ID Now Influenza A & B 2, ID NOW Strep A 2OZE · Special | 06/24/2022SE |
| K191534 | ID NOW Influenza A & B 2OCC · Special | 07/11/2019SE |
Questions and answers
When was BinaxNOW COVID-19 Antigen Self Test cleared by the FDA?
BinaxNOW COVID-19 Antigen Self Test (K243518) received a 510(k) decision of Substantially Equivalent on February 11, 2025, 90 days after the submission was received.
What is the product code of K243518?
The FDA product code is QYT – Over-The-Counter Covid-19 Antigen Test, a Class II (moderate risk) device regulated under 21 CFR 866.3984.